VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer

References

• WeltiJLogesSDimmelerSCarmelietPRecent molecular discoveries in angiogenesis and antiangiogenic therapies in cancerJ Clin Invest201312383190320023908119
   PubMed Web of Science ®Google Scholar
• RibattiDDjonovVIntussusceptive microvascular growth in tumorsCancer Lett2012316212613122197620
   PubMedGoogle Scholar
• CarmelietPJainRKAngiogenesis in cancer and other diseasesNature2000407680124925711001068
   PubMed Web of Science ®Google Scholar
• RamanathanROlexALDozmorovMBearHDFernandezLJTakabeKAngiopoietin pathway gene expression associated with poor breast cancer survivalBreast Cancer Res Treat2017162119119828062977
   PubMedGoogle Scholar
• JainRKDudaDGClarkJWLoefflerJSLessons from phase III clinical trials on anti-VEGF therapy for cancerNat Clin Pract Oncol200631244016407877
   PubMedGoogle Scholar
• LaiSRAndrewsLGTollefsbolTORNA interference using a plasmid construct expressing short-hairpin RNAMethods Mol Biol2007405313718369815
   PubMedGoogle Scholar
• BarataPSoodAKHongDSRNA-targeted therapeutics in cancer clinical trials: current status and future directionsCancer Treat Rev201650354727612280
   PubMed Web of Science ®Google Scholar
• DorsettYTuschlTsiRNAs: applications in functional genomics and potential as therapeuticsNat Rev Drug Discov20043431832915060527
   PubMed Web of Science ®Google Scholar
• OfekPTiramGSatchi-FainaroRAngiogenesis regulation by nanocarriers bearing RNA interferenceAdv Drug Deliv Rev Epub201722
   PubMedGoogle Scholar
• LuJJLangerRChenJA novel mechanism is involved in cationic lipid-mediated functional siRNA deliveryMol Pharm20096376377119292453
   PubMed Web of Science ®Google Scholar
• KnudsenKBNorthevedHKumarPEIn vivo toxicity of cationic micelles and liposomesNanomedicine201511246747725168934
   PubMed Web of Science ®Google Scholar
• LeeKBaeKHLeeYLeeSHAhnCHParkTGPluronic/polyethylenimine shell crosslinked nanocapsules with embedded magnetite nanocrystals for magnetically triggered delivery of siRNAMacromol Biosci201010323924519924685
   PubMed Web of Science ®Google Scholar
• MaoSSunWKisselTChitosan-based formulations for delivery of DNA and siRNAAdv Drug Deliv Rev2010621122719796660
   PubMed Web of Science ®Google Scholar
• ZhouJWuJHafdiNBehrJPErbacherPPengLPAMAM dendrimers for efficient siRNA delivery and potent gene silencingChem Commun20062223622364
   PubMedGoogle Scholar
• MaitraACalcium phosphate nanoparticles: second-generation nonviral vectors in gene therapyExpert Rev Mol Diagn20055689390516255631
   PubMed Web of Science ®Google Scholar
• ZhangJSunXShaoRLiangWGaoJChenJPolycation liposomes combined with calcium phosphate nanoparticles as a non-viral carrier for siRNA deliveryJ Drug Deliv Sci Technol201530pt A16
   Google Scholar
• ChenJLWangHGaoJQChenHLLiangWQLiposomes modified with polycation used for gene delivery: preparation, characterization and transfection in vitroInt J Pharm20073431–225526117624698
   PubMedGoogle Scholar
• ChenJYuZChenHGaoJLiangWTransfection efficiency and intracellular fate of polycation liposomes combined with protamineBiomaterials20113251412141821047681
   PubMed Web of Science ®Google Scholar
• WeidnerNSempleJPWelchWRFolkmanJTumor angiogenesis and metastasis – correlation in invasive breast carcinomaN Engl J Med1991324118
   PubMed Web of Science ®Google Scholar
• BergersGBenjaminLETumorigenesis and the angiogenic switchNat Rev Cancer20033640141012778130
   PubMed Web of Science ®Google Scholar
• HeSZhangDChengFGongFGuoYApplications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expressionMol Biol Rep20093682153216319117119
   PubMedGoogle Scholar
• KimHJKimAMiyataKKataokaKRecent progress in development of siRNA delivery vehicles for cancer therapyAdv Drug Deliv Rev2016104617727352638
   PubMed Web of Science ®Google Scholar
• RaoNMCationic lipid-mediated nucleic acid delivery: beyond being cationicChem Phys Lipids2010163324525220060819
   PubMed Web of Science ®Google Scholar
• KakizawaYFurukawaSKataokaKBlock copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA deliveryJ Control Release200497234535615196761
   PubMed Web of Science ®Google Scholar
• LeeuwenburghSCAnaIDJansenJASodium citrate as an effective dispersant for the synthesis of inorganic-organic composites with a nanodispersed mineral phaseActa Biomater20106383684419751849
   PubMed Web of Science ®Google Scholar
• LiJYangYHuangLCalcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumorJ Control Release2012158110811422056915
   PubMed Web of Science ®Google Scholar
• KovtunAHeumannREppleMCalcium phosphate nanoparticles for the transfection of cellsBiomed Mater Eng2009192–324124719581719
   PubMedGoogle Scholar
• GorskiSAVogelJDoudnaJARNA-based recognition and targeting: sowing the seeds of specificityNat Rev Mol Cell Biol201718421522828196981
   PubMed Web of Science ®Google Scholar
• SelvamCMutisyaDPrakashSRangannaKThilagavathiRTherapeutic potential of chemically modified siRNA: recent trendsChem Biol Drug Des Epub201745
   Google Scholar
• SalvaETuranSOErenFAkbugaJThe enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1alpha and VEGFInt J Pharm2015478114715425445537
   PubMed Web of Science ®Google Scholar
• YamasakiMMurakamiINakanoKCarboplatin plus weekly paclitaxel combined with bevacizumab as first-line treatment for non-small cell lung cancerAnticancer Res201737292392828179353
   PubMedGoogle Scholar
• TangYSoroushFTongZKianiMFWangBTargeted multidrug delivery system to overcome chemoresistance in breast cancerInt J Nanomedicine20171267168128176940
   PubMed Web of Science ®Google Scholar
• HanLTangCYinCDual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNABiomaterials201560425225982552
   PubMed Web of Science ®Google Scholar
• FengQYuMZWangJCSynergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticlesBiomaterials201435185028503824680191
   PubMed Web of Science ®Google Scholar